Vanda Pharmaceuticals
VNDA
#7804
Rank
C$0.51 B
Marketcap
C$8.55
Share price
-0.32%
Change (1 day)
43.75%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$56.17 Million a decrease over its 2023 earnings that were of -C$19.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion202.23%
2024 -C$56.17 Million191.43%
2023 -C$19.28 Million-320.45%
2022 C$8.74 M-84.99%
2021 C$58.24 M54.8%
2020 C$37.62 M19.42%
2019 C$31.5 M4.93%
2018 C$30.02 M-228.6%
2017 -C$23.35 Million-8.98%
2016 -C$25.66 Million-53.79%
2015 -C$55.51 Million-30.18%
2014 -C$79.5 Million173.08%
2013 -C$29.12 Million-25.33%
2012 -C$38.99 Million163.61%
2011 -C$14.79 Million-221.15%
2010 C$12.2 M-124.53%
2009 -C$49.77 Million-29.44%
2008 -C$70.54 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$90.76 Million170.55%
2005 -C$33.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.88 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.80 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.62 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.99 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.16 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.25 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.88 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA